Please note that the availability of compounded semaglutide may change based on ongoing regulatory updates and pharmacy guidelines
Treatment is subject to a pharmacist suitability assessment
Understanding and Managing Plateaus Hitting a plateau is a normal part of the GLP-1 process, often lasting several weeks
For researchers doing microdosing tirzepatide protocols , the 2.0mL dilution provides the best accuracy for sub-milligram doses
Learn about our Texas GLP-1 program Semaglutide Weight Loss in Houston, TX Physician-guided semaglutide programs for Houston patients Not sure which is right for you
The STEP (Semaglutide Treatment Effect in People with Obesity) clinical trial program provided robust evidence for semaglutides efficacy: STEP 1: Participants receiving semaglutide 2.4 mg weekly lost an average of 14.9% of body weight over 68 weeks, compared to 2.4% for placebo (Wilding et al., New England Journal of Medicine , 2021) STEP 2: In patients with type 2 diabetes, semaglutide produced 9.6% weight loss over 68 weeks STEP 3: Combined with intensive behavioral therapy, semaglutide produced 16.0% weight loss STEP 5: Weight loss was maintained over 104 weeks with continued treatment Head-to-Head Comparison: Mechanism of Action The fundamental difference between tesofensine and semaglutide lies in where and how they act in the body